Rock Springs Capital Management LP - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 74 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$10,605,000
-2.9%
364,800
+1.2%
0.23%
-0.4%
Q4 2020$10,921,000
+90.4%
360,500
+0.0%
0.23%
+58.9%
Q3 2020$5,735,000
-18.7%
360,454
+0.9%
0.15%
-24.7%
Q2 2020$7,055,000
+63.0%
357,409
+1.8%
0.19%
+8.4%
Q1 2020$4,329,000
-33.3%
351,1000.0%0.18%
-12.7%
Q4 2019$6,492,000
+33.5%
351,1000.0%0.20%
+5.7%
Q3 2019$4,863,000
-5.4%
351,1000.0%0.19%
+4.3%
Q2 2019$5,140,000351,1000.19%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$232,513,00049.48%
Ponoi II Management, LLC 1,298,908$16,652,00045.25%
Ponoi Management, LLC 1,298,908$16,652,00026.29%
Euclidean Capital LLC 746,674$9,572,0008.14%
StepStone Group LP 1,573,357$20,170,0002.16%
First Light Asset Management, LLC 1,135,884$14,562,0001.69%
Lexington Partners L.P. 110,428$1,416,0000.73%
Rubric Capital Management LP 797,588$10,225,0000.54%
Boxer Capital, LLC 500,000$6,410,0000.41%
DAFNA Capital Management LLC 107,653$1,380,0000.38%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders